Explore more publications!
Jordan Technology Report
Got News to Share?

Jordan Technology Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Technology Report.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 12, 2025

Novartis breaks ground on flagship manufacturing hub in North Carolina
December 12, 2025

Novartis breaks ground on flagship manufacturing hub in North Carolina

Indeterminate GlobeNewswire
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
December 12, 2025

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path

Indeterminate GlobeNewswire
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
December 12, 2025

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer

Indeterminate GlobeNewswire
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
December 12, 2025

Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025

Indeterminate GlobeNewswire
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
December 12, 2025

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

Indeterminate GlobeNewswire
BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years
December 12, 2025

BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years

Indeterminate GlobeNewswire
RentRedi Launches AI-powered Accounting Suite
December 12, 2025

RentRedi Launches AI-powered Accounting Suite

Indeterminate GlobeNewswire
SciChart strengthens its role in F1 Data Visualization as the sport’s software-driven engineering demands intensify
December 12, 2025

SciChart strengthens its role in F1 Data Visualization as the sport’s software-driven engineering demands intensify

Indeterminate GlobeNewswire
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
December 12, 2025

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Indeterminate GlobeNewswire
RentStac Expands Digital Real Estate Infrastructure with New Platform Features and Reports Strong Early Adoption
December 12, 2025

RentStac Expands Digital Real Estate Infrastructure with New Platform Features and Reports Strong Early Adoption

Indeterminate GlobeNewswire
STACK Infrastructure Appoints Matt VanderZanden as Chief Executive Officer, STACK Americas
December 12, 2025

STACK Infrastructure Appoints Matt VanderZanden as Chief Executive Officer, STACK Americas

Indeterminate GlobeNewswire
Elektrische Anwendungen für die Seefahrt: Tests mit Supraleitern und Superkondensatoren aus dem Projekt V-ACCESS wurden in Triest erfolgreich abgeschlossen
December 12, 2025

Elektrische Anwendungen für die Seefahrt: Tests mit Supraleitern und Superkondensatoren aus dem Projekt V-ACCESS wurden in Triest erfolgreich abgeschlossen

Indeterminate GlobeNewswire
Aplicaciones eléctricas navales: completadas con éxito en Trieste las pruebas de superconductores y supercondensadores del proyecto V-ACCESS
December 12, 2025

Aplicaciones eléctricas navales: completadas con éxito en Trieste las pruebas de superconductores y supercondensadores del proyecto V-ACCESS

Indeterminate GlobeNewswire
Applicazioni elettriche navali: completati con successo a Trieste i test sui superconduttori e sui supercondensatori del progetto V-ACCESS
December 12, 2025

Applicazioni elettriche navali: completati con successo a Trieste i test sui superconduttori e sui supercondensatori del progetto V-ACCESS

Indeterminate GlobeNewswire
Maritieme elektrische toepassingen: testen van supergeleiders en supercondensatoren uit het V-ACCESS-project succesvol afgerond in Triëst
December 12, 2025

Maritieme elektrische toepassingen: testen van supergeleiders en supercondensatoren uit het V-ACCESS-project succesvol afgerond in Triëst

Indeterminate GlobeNewswire
Applications navales électriques : les tests des supraconducteurs et supercondensateurs du projet V-ACCESS ont été menés avec succès à Trieste
December 12, 2025

Applications navales électriques : les tests des supraconducteurs et supercondensateurs du projet V-ACCESS ont été menés avec succès à Trieste

Indeterminate GlobeNewswire
Spryker sichert sich Kapitalerhöhung zur Stärkung der Marktführerschaft im B2B-Commerce
December 12, 2025

Spryker sichert sich Kapitalerhöhung zur Stärkung der Marktführerschaft im B2B-Commerce

Indeterminate GlobeNewswire
Spryker lève des fonds pour accélérer son leadership sur le marché du commerce B2B
December 12, 2025

Spryker lève des fonds pour accélérer son leadership sur le marché du commerce B2B

Indeterminate GlobeNewswire
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
December 12, 2025

Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

Indeterminate GlobeNewswire
SEALSQ Appoints Rolf Gobet as Director of Its Geneva Quantum Center of Excellence
December 12, 2025

SEALSQ Appoints Rolf Gobet as Director of Its Geneva Quantum Center of Excellence

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions